A mouse model for adult cardiac-specific gene deletion with CRISPR/Cas9

Kelli J. Carroll,Catherine A. Makarewich,John McAnally,Douglas M. Anderson,Lorena Zentilin,Ning Liu,Mauro Giacca,Rhonda Bassel-Duby,Eric N. Olson

DOI: https://doi.org/10.1073/pnas.1523918113

IF: 11.1

2015-12-30

Proceedings of the National Academy of Sciences

Abstract:Significance The recent development of the clustered regularly interspaced short palindromic repeats (CRISPR)-associated (Cas)9 system has greatly simplified the process of genomic editing. However, it has remained difficult to induce mutations in postnatal animals due to delivery challenges of the CRISPR/Cas9 components. Here, we report the generation of a transgenic mouse line that expresses Cas9 exclusively in cardiomyocytes. By using Adeno-Associated Virus 9 to deliver single-guide RNA (sgRNA) this method can rapidly induce genomic insertions and deletions in the heart. As proof of concept, administration of sgRNA against the Myh6 gene induced Myh6 editing, resulting in cardiomyopathy and heart failure in the cardiac-specific Cas9 mouse. This transgenic mouse model offers a valuable tool for cardiovascular research, as a straightforward strategy to edit genes of interest in the heart.